As of May 18
| +1.35 / +0.89%|
The 7 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 160.00, with a high estimate of 165.00 and a low estimate of 148.00. The median estimate represents a +4.60% increase from the last price of 152.97.
The current consensus among 8 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.